Clinical Trial Update: Neurocognitive Training Integrated in OPUS Treatment Versus OPUS Treatment-as-usual [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing neurocognitive training integrated into OPUS treatment versus OPUS treatment-as-usual for schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Neurocom | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED